by Ophélie Rostaing | May 13, 2024 | News, Patch Updates
IMPACTS: Addition of four new CYP isoforms for SoM predictions (2A6, 2B6, 2C8, and 2E1). Use of SASA correction factor to improve activation energy assignment. SELECT: Use of Tversky index in addition to Tanimoto coefficient for seach similarity. CONVERT: Can convert...
by Ophélie Rostaing | Feb 28, 2024 | News
In the quest for new medicines, developers seek to make AI their divining rod. Petrina Kamya may be a biochemist, but the research and development centre she runs in Montreal is conspicuously devoid of lab coats, test tubes or chemicals. Instead, the newly...
by Ophélie Rostaing | Jan 17, 2024 | News
Molecular Forecaster Inc. Partners with NMX Research and Solutions Inc. to Deliver Expanded Hypothesis-Driven Drug Design Services MONTREAL, QUEBEC, January 17, 2024 – Molecular Forecaster Inc. (MFI) is excited to announce a new partnership with NMX Research and...
by Rebecca Johnston | Jan 8, 2024 | News, News
We have a few words that sum up the last year or two at MFI: evolution is a good one. We’re an early-stage business, with big projects, great partners and customers, and lofty goals. We’re also a values-driven company, focused on our corporate and social...
by babbasipour | Aug 7, 2023 | News
In the ever-evolving world of machine learning in drug discovery, benchmarking datasets play a pivotal role in driving progress and innovation. They serve as a critical tool for evaluating and comparing different algorithms and models. However, as the field advances,...
